Skip to content

Inspire Medical Systems INSP Q4 2024 Annual earnings

Reported February 10, 2025 · After market close

Revenue$239.7MIn line
EPS$1.15Beat by $0.41
Revenue estimate$239.8M
EPS estimate$0.74

Next report

Aug 3, 2026 (In 5 days)
Revenue estimate$194.7M
EPS estimate-$0.22

Financials

Q4 2024

Income statement

See full
Revenue$239.7M+24.5%
Gross profit$203.7M+23.9%
Operating income$31.9M
Net income$35.2M
EPS (diluted)$1.15

Balance sheet

See full
Cash & equivalents$150.2M-19.1%
Total debt$31.8M+28.0%
Total equity$689.7M+20.5%
Total assets$808.4M+19.4%

Cash flow

See full
Operating cash flow$69.2M+301%
CapEx$7.0M-12.5%
Free cash flow$62.2M+573%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$5.56B-7.5%
Enterprise value$5.44B-7.0%
P/E103.8×
P/S6.9×-2.7×

Profitability

See full
Gross margin84.7%+0.1pp
Operating margin4.5%
Net margin6.7%
FCF margin11.4%+11.2pp

Returns & leverage

See full
Return on equity8.5%
Debt / equity0.0×
Current ratio7.1×-0.5×

Segments

By segment

See full
Operating Segment$239.7M+53.5%

By geography

See full
United States$231.6M

Versus estimates

Ask the moment Inspire Medical Systems reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Inspire Medical Systems report Q4 2024 earnings?
Inspire Medical Systems (INSP) reported Q4 2024 earnings on February 10, 2025 after market close.
What were Inspire Medical Systems's Q4 2024 revenue and EPS?
Inspire Medical Systems reported revenue of $239.7M and eps of $1.15 for Q4 2024.
Did Inspire Medical Systems beat estimates in Q4 2024?
Revenue missed the consensus estimate of $239.8M by $44.7K. EPS beat the consensus estimate of $0.74 by $0.41.
Where can I find Inspire Medical Systems's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001609550-25-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.